摘要
《中国药典》2020年版即将颁布实施。本文从《中国药典》2020年版二部的制定过程、体例优化、品种遴选、通用名规范、凡例修订以及正文品种标准增修订情况等方面逐一进行介绍,并相应举例说明,以便读者更好地理解和执行新版药典。
The Pharmacopeia of the People′s Republic of China 2020(The Chinese Pharmacopoeia 2020,ChP 2020)will be promulgated and implemented soon.This article introduces the establishment procedure of drug quality standards,standard format optimization,drug selection,drug generic names and main revision of monographs and general notices of the ChP 2020(Volume Ⅱ),and provides some analysis and explanation examples,which will help the readers to understand and implement the ChP 2020.
作者
岳志华
王志军
程奇蕾
王绯
周怡
张筱红
岳瑞齐
李慧义
YUE Zhihua;WANG Zhijun;CHENG Qilei;WANG Fei;ZHOU Yi;ZHANG Xiaohong;YUE Ruiqi;LI Huiyi(Chinese Pharmacopoeia Commission,Beijing 100061,China)
出处
《中国药品标准》
CAS
2020年第4期285-289,共5页
Drug Standards of China
关键词
《中华人民共和国药典》2020年版二部
增修订
药品标准提高
The Chinese Pharmacopoeia 2020(Volume Ⅱ)(ChP 2020,volume Ⅱ)
Updates and amendments of the drug quality standards
Drug quality standard improvement
